Cargando…
Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome
BACKGROUND: Marfan syndrome (MFS) is a dominant monogenic disorder caused by mutations in fibrillin 1 (FBN1). Rarely, compound heterozygosity for FBN1 mutations has been described. METHODS: A large kindred with MFS was assessed clinically over decades, and genetically using exome and/or Sanger seque...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057098/ https://www.ncbi.nlm.nih.gov/pubmed/31950671 http://dx.doi.org/10.1002/mgg3.1116 |
_version_ | 1783503591859814400 |
---|---|
author | McInerney‐Leo, Aideen M. West, Jennifer Wheeler, Lawrie Leo, Paul J. Summers, Kim M. Anderson, Lisa Brown, Matthew A. West, Malcolm Duncan, Emma L. |
author_facet | McInerney‐Leo, Aideen M. West, Jennifer Wheeler, Lawrie Leo, Paul J. Summers, Kim M. Anderson, Lisa Brown, Matthew A. West, Malcolm Duncan, Emma L. |
author_sort | McInerney‐Leo, Aideen M. |
collection | PubMed |
description | BACKGROUND: Marfan syndrome (MFS) is a dominant monogenic disorder caused by mutations in fibrillin 1 (FBN1). Rarely, compound heterozygosity for FBN1 mutations has been described. METHODS: A large kindred with MFS was assessed clinically over decades, and genetically using exome and/or Sanger sequencing. RESULTS: A previously identified FBN1 missense variant (p.Tyr754Cys) was confirmed in all subjects with MFS. An additional variant (p.Met2273Thr), previously associated with incomplete MFS, was identified in three siblings. These three compound heterozygous individuals had aortic dilatation at early age (all <30 years): one also had cerebral and ocular aneurysms; and one, who had undergone surgical repair aged 18 years, died from aortic dissection at 31 years. In contrast, their heterozygous father (p.Tyr754Cys) with MFS died at 57 years (myocardial infarction) without requiring surgical intervention and one heterozygous (p.Tyr754Cys) sibling has aortic dilatation presenting >40 years but not requiring surgical intervention. Another heterozygous (p.Tyr754Cys) sibling did require aortic root repair (28 years). The heterozygous (p.Met2273Thr) mother had aortic dilatation diagnosed at age 68 years but has not required surgical repair. CONCLUSION: Although compound heterozygosity or homozygosity is rare in MFS, it should be considered when there is an unusually severe phenotype in a subset of family members. |
format | Online Article Text |
id | pubmed-7057098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70570982020-03-12 Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome McInerney‐Leo, Aideen M. West, Jennifer Wheeler, Lawrie Leo, Paul J. Summers, Kim M. Anderson, Lisa Brown, Matthew A. West, Malcolm Duncan, Emma L. Mol Genet Genomic Med Clinical Reports BACKGROUND: Marfan syndrome (MFS) is a dominant monogenic disorder caused by mutations in fibrillin 1 (FBN1). Rarely, compound heterozygosity for FBN1 mutations has been described. METHODS: A large kindred with MFS was assessed clinically over decades, and genetically using exome and/or Sanger sequencing. RESULTS: A previously identified FBN1 missense variant (p.Tyr754Cys) was confirmed in all subjects with MFS. An additional variant (p.Met2273Thr), previously associated with incomplete MFS, was identified in three siblings. These three compound heterozygous individuals had aortic dilatation at early age (all <30 years): one also had cerebral and ocular aneurysms; and one, who had undergone surgical repair aged 18 years, died from aortic dissection at 31 years. In contrast, their heterozygous father (p.Tyr754Cys) with MFS died at 57 years (myocardial infarction) without requiring surgical intervention and one heterozygous (p.Tyr754Cys) sibling has aortic dilatation presenting >40 years but not requiring surgical intervention. Another heterozygous (p.Tyr754Cys) sibling did require aortic root repair (28 years). The heterozygous (p.Met2273Thr) mother had aortic dilatation diagnosed at age 68 years but has not required surgical repair. CONCLUSION: Although compound heterozygosity or homozygosity is rare in MFS, it should be considered when there is an unusually severe phenotype in a subset of family members. John Wiley and Sons Inc. 2020-01-16 /pmc/articles/PMC7057098/ /pubmed/31950671 http://dx.doi.org/10.1002/mgg3.1116 Text en © 2020 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Reports McInerney‐Leo, Aideen M. West, Jennifer Wheeler, Lawrie Leo, Paul J. Summers, Kim M. Anderson, Lisa Brown, Matthew A. West, Malcolm Duncan, Emma L. Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome |
title | Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome |
title_full | Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome |
title_fullStr | Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome |
title_full_unstemmed | Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome |
title_short | Compound heterozygous mutations in FBN1 in a large family with Marfan syndrome |
title_sort | compound heterozygous mutations in fbn1 in a large family with marfan syndrome |
topic | Clinical Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057098/ https://www.ncbi.nlm.nih.gov/pubmed/31950671 http://dx.doi.org/10.1002/mgg3.1116 |
work_keys_str_mv | AT mcinerneyleoaideenm compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome AT westjennifer compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome AT wheelerlawrie compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome AT leopaulj compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome AT summerskimm compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome AT andersonlisa compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome AT brownmatthewa compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome AT westmalcolm compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome AT duncanemmal compoundheterozygousmutationsinfbn1inalargefamilywithmarfansyndrome |